Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Yew Bio-Pharm Group, Inc. (OTC: YEWB).

Full DD Report for YEWB

You must become a subscriber to view this report.


Recent News from (OTC: YEWB)

Yew Bio-Pharm Reports Financial Results for 2018 Second Quarter
EL MONTE, Calif., Aug. 14, 2018 (GLOBE NEWSWIRE) -- Yew Bio-Pharm Group, Inc. (“Yew Bio” or the “Company”) (YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine, handicraft products made from yew...
Source: GlobeNewswire
Date: August, 14 2018 16:10
Yew Bio-Pharm Group Reports 2018 First Quarter Financial Results
EL MONTE, Calif. , May 15, 2018 /PRNewswire/ -- Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine, handicraft products made from yew timber and yew candle an...
Source: PR Newswire
Date: May, 15 2018 16:10
Yew Bio-Pharm reports Q4 results
Yew Bio-Pharm ( OTCQB:YEWB ): Q4 EPS of -$0.14 More news on: Yew Bio-Pharm Group, Inc., Earnings news and commentary, Consumer stocks news, , Read more ...
Source: SeekingAlpha
Date: April, 02 2018 16:58
Yew Bio-Pharm Group Reports 2017 Fourth Quarter and Full Year Financial Results
EL MONTE, Calif. , April 2, 2018 /PRNewswire/ -- Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (OTCQB: YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine, handicraft products made from yew timber and yew candle...
Source: PR Newswire
Date: April, 02 2018 16:10
Yew Bio-Pharm Group Reports 2017 Third Quarter Financial Results
EL MONTE, Calif. , Nov. 13, 2017 /PRNewswire/ -- Yew Bio-Pharm Group, Inc. ("Yew Bio" or the "Company") (YEWB), a major grower and seller of yew trees, yew raw materials used in the manufacture of traditional Chinese medicine, handicraft products made from yew timber and yew candle and so...
Source: PR Newswire
Date: November, 13 2017 16:05

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-12-12N/A0.16N/AN/A0
2018-12-110.160.160.160.1620,000
2018-12-10N/A0.16N/AN/A0
2018-12-07N/A0.16N/AN/A0
2018-12-06N/A0.16N/AN/A0

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-1120,00020,000100.0000Short
2018-11-283,4523,57096.6947Short
2018-11-122,5005,00050.0000Short
2018-10-311010100.0000Short
2018-10-175,1005,100100.0000Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on YEWB.


About Yew Bio-Pharm Group, Inc. (OTC: YEWB)

Logo for Yew Bio-Pharm Group, Inc. (OTC: YEWB)

A major grower and seller of yew trees and manufacturer of products made from yew trees in China, including potted yew trees for display in homes and offices, and handicrafts. We also sell branches and leaves of yew trees for the manufacture of Traditional Chinese Medicine CM containing taxol, which Traditional Chinese Medicine has been approved in the PRC for use as a secondary treatment of certain cancers, meaning it must be administered in combination with other pharmaceutical drugs. The yew industry is highly regulated in the PRC because the Northeast yew tree is considered an endangered species.

 

Contact Information

 

 

Current Management

  • Zhiguo Wang / CEO, CFO
  • Guifang Qi / Treasurer, Secretary
  • Zhiguo Wang / Chairman
  • Guifang Qi /
  • Xuehai Wu /

Current Share Structure

  • Market Cap: $18,025,000 - 03/09/2018
  • Authorized: 140,000,000 - 02/28/2018
  • Issue and Outstanding: 51,500,000 - 02/28/2018
  • Float: 13,999,999 - 04/11/2016

 


Recent Filings from (OTC: YEWB)

Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 15 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 10 2018
Annual report with a comprehensive overview of the company
Filing Type: 10-KFiling Source: edgar
Filing Date: April, 02 2018
Additional information statement materials - definitive
Filing Type: DEFA14CFiling Source: edgar
Filing Date: November, 14 2017
All other definitive information statements
Filing Type: DEF 14CFiling Source: edgar
Filing Date: November, 14 2017
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 13 2017
Preliminary proxy statement containing all other information
Filing Type: PRE 14CFiling Source: edgar
Filing Date: November, 02 2017

 

 


Daily Technical Chart for (OTC: YEWB)

Daily Technical Chart for (OTC: YEWB)


Stay tuned for daily updates and more on (OTC: YEWB)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: YEWB)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in YEWB is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of YEWB and does not buy, sell, or trade any shares of YEWB. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/